Detalles de la búsqueda
1.
Understanding the patient experience in hepatocellular carcinoma: a qualitative patient interview study.
Qual Life Res
; 31(2): 473-485, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34115280
2.
A phase Ib study of the highly selective MET-TKI savolitinib plus gefitinib in patients with EGFR-mutated, MET-amplified advanced non-small-cell lung cancer.
Invest New Drugs
; 39(2): 477-487, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33052556
3.
First-in-Human Phase I Study of the Selective MET Inhibitor, Savolitinib, in Patients with Advanced Solid Tumors: Safety, Pharmacokinetics, and Antitumor Activity.
Clin Cancer Res
; 25(16): 4924-4932, 2019 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30952639
4.
A First-in-Human Study of the New Oral Selective Estrogen Receptor Degrader AZD9496 for ER+/HER2- Advanced Breast Cancer.
Clin Cancer Res
; 24(15): 3510-3518, 2018 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29440181
5.
Circulating Biomarkers and Resistance to Endocrine Therapy in Metastatic Breast Cancers: Correlative Results from AZD9496 Oral SERD Phase I Trial.
Clin Cancer Res
; 24(23): 5860-5872, 2018 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30082476
6.
Biomarker-Based Phase II Trial of Savolitinib in Patients With Advanced Papillary Renal Cell Cancer.
J Clin Oncol
; 35(26): 2993-3001, 2017 Sep 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28644771
7.
Leptin, BMI, and a Metabolic Gene Expression Signature Associated with Clinical Outcome to VEGF Inhibition in Colorectal Cancer.
Cell Metab
; 23(1): 77-93, 2016 Jan 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-26626460
8.
Correlation of lactate dehydrogenase isoenzyme profile with outcome in patients with advanced colorectal cancer treated with chemotherapy and bevacizumab or cediranib: Retrospective analysis of the HORIZON I study.
Clin Colorectal Cancer
; 13(1): 46-53, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24355210
9.
FGFR2, HER2 and cMet in gastric adenocarcinoma: detection, prognostic significance and assessment of downstream pathway activation.
Virchows Arch
; 464(2): 145-56, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24306956
10.
KRAS mutations are associated with inferior clinical outcome in patients with metastatic colorectal cancer, but are not predictive for benefit with cediranib.
Eur J Cancer
; 49(10): 2424-32, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23510802
11.
Comparison of KRAS Mutation Assessment in Tumor DNA and Circulating Free DNA in Plasma and Serum Samples.
Clin Med Insights Pathol
; 5: 15-22, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22661904
12.
Antitumor effects and biomarkers of activity of AZD0530, a Src inhibitor, in pancreatic cancer.
Clin Cancer Res
; 15(12): 4138-46, 2009 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19509160
13.
Tenth Annual Phase I Clinical Trials Conference. Improving risk management and safety and increasing efficiency in phase I clinical trials. 10-11 February 2009, London, UK.
IDrugs
; 12(4): 220-2, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19350463
14.
Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritis.
Arthritis Rheum
; 50(12): 3783-91, 2004 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-15593225
Resultados
1 -
14
de 14
1
Próxima >
>>